BioAdaptives Inc logo

BioAdaptives Inc

$ 0.00 -0.0001 (-4%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 249.00K
Enterprise V:
$ 660.00K
Volume:
5.23K
Avg Vol (2M):
3.13M
Volume:
5.23K
Market Cap $:
249.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
3.13M
Enterprise Value $:
660.00K
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
BioAdaptives Inc is engaged in developing research-based clinically validated natural wellness solutions. The firm focuses on the research of primitive cells like stem cells and their derivatives. Its products include dietary supplements, specialty food items, and proprietary methods of optimizing the bioelectromagnetic availability of foods and beverages. Its product lines include PrimiCell, a primitive cell activator, PrimiLungs, a lung immune defense product, and PluriPain.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset -21.67
Debt-to-Equity -0.3
Debt-to-EBITDA -1.14
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -198.58
Distress
Grey
Safe
Beneish M-Score -55.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 39.54
9-Day RSI 43.73
14-Day RSI 44.87
6-1 Month Momentum % -54.55
12-1 Month Momentum % -90.38

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.04
Quick Ratio 0.03
Cash Ratio 0.03
Days Inventory 272.09
Days Payable 99.55

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.6

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 42.11
Operating Margin % -3515.79
Net Margin % -4421.05
ROA % -677.42
ROIC % -54.05

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 2.4
EV-to-EBIT -1.2
EV-to-EBITDA -1.63
EV-to-Revenue 34.26
EV-to-FCF -3.34
Earnings Yield (Greenblatt) % -83.13

Financials

BDPT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BDPT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.019
EPS (TTM) ($) -0.014
Beta -0.31
Volatility % 60.16
14-Day RSI 44.87
14-Day ATR ($) 0.000224
20-Day SMA ($) 0.00256
12-1 Month Momentum % -90.38
52-Week Range ($) 0.00205 - 0.0485
Shares Outstanding (Mil) 103.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioAdaptives Inc Filings

Document Form Filing Date
No Filing Data

BioAdaptives Inc Analysis

Share your research

Headlines

See More
No news.